Our site uses cookies to offer you a better user experience. By continuing to use this site, you agree to our use of cookies. To find out more, read our Privacy and Cookies policies.
  • All Journals
  • Exploration of Medicine
  • Exploration of Targeted Anti-tumor Therapy
  • Exploration of Immunology
  • Exploration of Neuroprotective Therapy
  • Exploration of Digestive Diseases
  • Exploration of Neuroscience
  • Exploration of Musculoskeletal Diseases
  • Exploration of Drug Science
  • Exploration of Asthma & Allergy
  • Exploration of Foods and Foodomics
  • Exploration of Digital Health Technologies
  • Exploration of Cardiology
  • Exploration of BioMat-X
  • Exploration of Endocrine and Metabolic Diseases
  • All
  • Article Title
  • Abstract
  • Keywords
  • Author
  • Institution
1740 results in Open Exploration
  • Relevance
  • Publication Date
Sort by :
Open Access Original Article
Assessing the capacity for mental manipulation in patients with statically-determined mild cognitive impairment using digital technology
Sheina Emrani ... David J. Libon
Published: February 28, 2021 Explor Med. 2021;2:86–97
This article belongs to the special issue Digital Biomarkers: The New Frontier for Medicine and Research
4418 30 2
Open Access Original Article
Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
Ibrahim H. Kankia ... Yusuf Y. Deeni
Published: April 30, 2021 Explor Target Antitumor Ther. 2021;2:187–203
2548 58 1
Open Access Editorial
Welcome message from the Editor-in-Chief
Lindsay A. Farrer
Published: February 29, 2020 Explor Med. 2020;1:1–3
2460 41 0
Open Access Review
Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment
Priyanka Singh ... Anita Kamra Verma
Published: February 16, 2022 Explor Med. 2022;3:22–42
This article belongs to the special issue Nanomedicine and Cancer Immunotherapy
3155 56 2
Open Access Editorial
Opening editorial for exploration in musculoskeletal diseases
Fernando Perez-Ruiz
Published: January 01, 2023 Explor Musculoskeletal Dis. 2023;1:1–3
2038 52 0
Open Access Case Report
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Davide Scalabrini ... Pietro Andreone
Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
1557 23 0
Open Access Review
Coronavirus disease 2019 and lung cancer: where are we?
Abrahams Ocanto ... Felipe Couñago
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1082–1094
This article belongs to the special issue COVID-19 and Cancer
2025 17 1
Open Access Original Article
Probiotic human alcohol dehydrogenase-4 expressing bacteria protects from diet-induced obesity and metabolic impairment: a new concept of disease prevention
Rajnish Prakash Singh ... Zvi Hayouka
Published: October 31, 2022 Explor Dig Dis. 2022;1:118–136
2782 61 0
Open Access Meeting Abstracts
Selected meeting abstracts of 2nd International Conference on Contemporary Oncology
Chouaib Salem
Published: June 28, 2024 Explor Target Antitumor Ther. 2024;5:789–799
1100 22 0
Open Access Review
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
Giuliano Palumbo ... Alessandro Morabito
Published: April 28, 2020 Explor Target Antitumor Ther. 2020;1:117–130
3892 65 2
Open Access Review
Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease
Noel C. Salvoza ... Natalia Rosso
Published: April 30, 2020 Explor Med. 2020;1:51–74
This article belongs to the special issue Exploring NAFLD/NASH
13019 259 20
Open Access Review
Understanding cardiac systolic performance beyond left ventricular ejection fraction
Elena-Laura Antohi, Ovidiu Chioncel
Published: April 30, 2020 Explor Med. 2020;1:75–84
8647 172 5
Open Access Review
Perspectives of nonalcoholic fatty liver disease research: a personal point of view
Amedeo Lonardo, Stefano Ballestri
Published: June 29, 2020 Explor Med. 2020;1:85–107
This article belongs to the special issue Exploring NAFLD/NASH
9260 132 26
Open Access Review
Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
Rachael Arthur ... Graham Packham
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:131–152
This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
9251 305 18
Open Access Original Article
Reduction of endoglin receptor impairs mononuclear cell-migration
Zhenying Han ... Hua Su
Published: June 29, 2020 Explor Med. 2020;1:136–148
3613 35 8
Open Access Original Article
Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study
Elisha M. Wachman ... Huiping Zhang
Published: June 29, 2020 Explor Med. 2020;1:124–135
This article belongs to the special issue The Biological Basis of Substance Use Disorders
4933 53 9
Open Access Meta-Analysis
GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis
Alessandro Mantovani ... Giovanni Targher
Published: June 29, 2020 Explor Med. 2020;1:108–123
This article belongs to the special issue Exploring Type 2 Diabetes Mellitus
5009 107 4
Open Access Review
An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
Irum Naz ... Kwang Seok Ahn
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:153–170
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
7272 107 17